Interleukin-32 gamma specific monoclonal antibody and developing IL-32 specific ELISA
Siyoung Lee1, Sunjong Kim, Suyoung Bae
1Department of Immunology, College of Medicine, Konkuk University, Chungju City, Chungbuk, Korea.
Hybridoma (2005)
|November 20, 2010
Summary
Researchers developed specific monoclonal antibodies for Interleukin-32 gamma (IL-32γ), a key proinflammatory cytokine. These antibodies will aid in measuring IL-32 levels in inflammatory diseases and understanding its role in immune responses.
Area of Science:
- Immunology
- Molecular Biology
- Cytokine Research
Background:
- Cytokines are crucial for immune defense but dysregulation causes autoinflammatory disorders.
- Interleukin-32 (IL-32) is a proinflammatory cytokine linked to various pathogens and diseases.
- IL-32 has six splice variants, with IL-32γ being the most active, but its role is unclear due to lack of detection tools.
Purpose of the Study:
- To develop specific monoclonal antibodies for detecting human IL-32γ.
- To provide a tool for measuring IL-32 levels in biological samples.
- To facilitate research into IL-32's function in immune responses and autoinflammatory diseases.
Main Methods:
- Recombinant human IL-32γ was expressed in Escherichia coli.
- Specific anti-human IL-32γ monoclonal antibodies were generated.
- Antibody efficacy was tested using cell culture supernatants and serum from IL-32γ transgenic mice.
Main Results:
- Successfully developed specific monoclonal antibodies targeting human IL-32γ.
- Validated antibody recognition of IL-32γ in cell culture and mouse serum.
- Established a tool for quantifying IL-32γ in biological samples.
Conclusions:
- The developed IL-32γ monoclonal antibodies are valuable tools for inflammatory disease research.
- These antibodies will enable precise measurement of IL-32 levels in patient serum.
- Further investigation into IL-32's precise function in immunity and autoinflammation is now possible.
